PMID: 8962093Dec 10, 1996Paper

The Gfi-1 protooncoprotein represses Bax expression and inhibits T-cell death

Proceedings of the National Academy of Sciences of the United States of America
H L GrimesP N Tsichlis

Abstract

The Gfi-1 protooncogene encodes a nuclear zinc-finger protein that carries a novel repressor domain, SNAG, and functions as a position- and orientation-independent active transcriptional repressor. The Gfi-1 repressor allows interleukin 2 (IL-2)-dependent T cells to escape G1 arrest induced by IL-2 withdrawal in culture and collaborates with c-myc and pim-1 for the induction of retrovirus-induced lymphomas in animals. Here we show that overexpression of Gfi-1 also inhibits cell death induced by cultivation of IL-2-dependent T-cell lines in IL-2-deficient media. Similarly, induction of Gfi-1 in primary thymocytes from mice carrying a metal-inducible Gfi-1 transgene inhibits cell death induced by cultivation in vitro. The protein and mRNA levels of the proapoptotic regulator Bax are down-regulated by Gfi-1 in both immortalized T-cell lines and primary transgenic thymocytes. The repression is direct and depends on several Gfi-1-binding sites in the p53-inducible Bax promoter. In addition to Bax, Gfi-1 also represses Bak, another apoptosis-promoting member of the Bcl-2 gene family. Therefore, Gfi-1 may inhibit apoptosis by means of its repression of multiple proapoptotic regulators. The antiapoptotic properties of Gfi-1 provide a p...Continue Reading

References

Apr 3, 1992·Cell·G I EvanD C Hancock
Jan 1, 1992·Analytical Biochemistry·W P Deng, J A Nickoloff
Dec 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·G W StuartR D Palmiter
Jun 1, 1995·Cancer Metastasis Reviews·J M Lee, A Bernstein
Oct 6, 1995·Science·C M KnudsonS J Korsmeyer
Jan 1, 1994·Cold Spring Harbor Symposia on Quantitative Biology·A BernsJ Jonkers
Jul 20, 1995·Cancer Letters·B HsuT J McDonnell
Apr 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F ChangK Syrjänen
Mar 1, 1995·Trends in Genetics : TIG·S J Korsmeyer
Dec 1, 1994·Immunology Today·G NúñezM González-García
Jun 3, 1994·Journal of Immunological Methods·W G TelfordP J Fraker
Jan 1, 1996·Genes & Development·E White
Aug 1, 1996·Molecular and Cellular Biology·P A Zweidler-MckayP N Tsichlis

❮ Previous
Next ❯

Citations

May 15, 2007·Immunologic Research·Arpita S Bharadwaj, Devendra K Agrawal
Aug 16, 2001·International Journal of Hematology·I SakaiS Fujita
Nov 7, 1998·Biochimica Et Biophysica Acta·D BaytelJ Don
Feb 1, 2003·Gene·J Nathan DavisShari Meyers
Jun 24, 1999·Cytokine & Growth Factor Reviews·R HofmeisterS K Durum
Jun 5, 2003·International Immunopharmacology·Kiyoshi Takatsu, Ai Kariyone
Sep 24, 2010·Leukemia·L T van der MeerB A van der Reijden
Nov 22, 2005·Oncogene·A G UrenM van Lohuizen
Jan 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·Suchitra BasuFan Dong
Feb 12, 2002·Journal of Virology·Dana R BroussardJaquelin P Dudley
Oct 1, 2004·Molecular and Cellular Biology·Hamed Jafar-Nejad, Hugo J Bellen
Mar 8, 2012·Molekuliarnaia biologiia·Iu N ZhukovaV N Danilenko
May 30, 2008·Frontiers in Bioscience : a Journal and Virtual Library·Zeyu XiongXiao-Feng Yang
Apr 15, 2004·Trends in Biochemical Sciences·Sharad Kumar, Dimitrios Cakouros
Dec 26, 2001·Proceedings of the National Academy of Sciences of the United States of America·S MalstromP N Tsichlis
May 2, 2003·Proceedings of the National Academy of Sciences of the United States of America·Zhijun Duan, Marshall Horwitz
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·N N AhmedP N Tsichlis
Mar 17, 2010·FEBS Letters·Jin Hyuk JungSungkwan An
Sep 17, 2011·Seminars in Immunology·Tarik Möröy, Cyrus Khandanpour
Feb 16, 2010·Journal of Molecular Biology·Soojin LeeZhengrong Wu
May 24, 2006·Critical Reviews in Oncology/hematology·Avedis KazanjianH Leighton Grimes
May 3, 2006·Insect Biochemistry and Molecular Biology·Jianwei Gao, Jeffrey G Scott
Oct 8, 2003·Hematology·Zhijun Duan, Marshall Horwitz
Oct 11, 2005·Critical Reviews in Oncology/hematology·Heather A Bruns, Mark H Kaplan
Feb 24, 2015·Cellular and Molecular Life Sciences : CMLS·Cristina López-RodríguezRosa Berga-Bolaños

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

CZI Human Cell Atlas Seed Network

The aim of the Human Cell Atlas (HCA) is to build reference maps of all human cells in order to enhance our understanding of health and disease. The Seed Networks for the HCA project aims to bring together collaborators with different areas of expertise in order to facilitate the development of the HCA. Find the latest research from members of the HCA Seed Networks here.